|
KR20200118081A
|
|
Electrical condensing aerosol device
|
|
MX2019006745A
|
|
Method of treating epilepsy.
|
|
US2018126098A1
|
|
Heat units using a solid fuel capable of undergoing an exothermic metal oxidation-reduction reaction propagated without an igniter
|
|
WO2017165816A1
|
|
Pediatric population pharmacokinetic model development
|
|
CN107750177A
|
|
Antistatic material in air flue is used for the purposes of hot aerosol coagulation method
|
|
CN107049996A
|
|
With a nicotine salt for salicylic acid formation
|
|
US2010300433A1
|
|
Substrates for Enhancing Purity or Yield of Compounds Forming a Condensation Aerosol
|
|
US2010055048A1
|
|
Acute treatment of headache with phenothiazine antipsychotics
|
|
US2010006092A1
|
|
Aerosol Drug Delivery Device Incorporating Percussively Activated Heat Packages
|
|
WO2009089550A1
|
|
Metal coordination complexes of volatile drugs
|
|
US2010068154A1
|
|
Printable igniters
|
|
US2010065052A1
|
|
Heating Units
|
|
US2010068155A1
|
|
Reactant Formulations and Methods for Controlled Heating
|
|
WO2008134668A2
|
|
Heat-labile prodrugs
|
|
WO2008112661A2
|
|
Heating unit for use in a drug delivery device
|
|
AU2008200911A1
|
|
Delivery of opioids through an inhalation route
|
|
WO2008080170A1
|
|
Mixed drug aerosol compositiions
|
|
US2007286816A1
|
|
Drug and excipient aerosol compositions
|
|
US2006233717A1
|
|
Delivery of compounds for the treatment of headache through an inhalation route
|
|
WO2006044421A2
|
|
Cardiac safe, rapid medication delivery
|
